Skip to main content
Electronic Physician logoLink to Electronic Physician
. 2013 Feb 1;5(1):623–630. doi: 10.14661/2013.623-630

Effect of six-week aerobic exercise on Chemerin and Resistin concentration in hypertensive postmenopausal women

Atieh Aghapour 1,, Parvin Farzanegi 2
PMCID: PMC4477779  PMID: 26120393

Abstract

Background:

Physical activity reduces symptoms of cardiovascular diseases. The aim of this study was to examine the effect of six-week aerobic exercise upon Chemerin and Resistin concentration in women with menopause who had hypertension.

Methods:

The population of this quasi-experimental study included postmenopausal women diagnosed with hypertension. They were 50 to 55 years old and lived in Amol, a city in north part of Iran. Twenty volunteers were filled the personal consent and Health Questionnaire. They were randomly assigned to Experimental and control groups equally (n=10 per group). The experimental group conducted a 6-week aerobic training program from 8–10am every day.

Results:

Endurance exercise decreased Chemerin (t=10.41, P<0.000) and Resistin (t=2.42, P<0.051); indicating the decline of inflammation and cardiovascular disease.

Conclusion:

Considering anti-inflammatory effects of exercise, training plays an important role in reducing inflammatory indices in human; and endurance training can be a good strategy to deal with inflammation and cardiac- vascular risk factors.

Keywords: Aerobic exercise, Chemerin, Resistin, Postmenopausal

1. Introduction

Nearly 233 percent growth in 2025 is expected to be in the world’s elderly population- the majority are women (1). Menopause is not a disease, but is associated with many physical and psychological problems (2). Studies show that the incidence of some diseases such as hypertension in women increases after menopause (3, 4). Hypertension is a global problem; a disease that is asymptomatic and often called the silent killer (5). According to the World Health Organization, hypertension is the third leading cause of mortality in humans worldwide (6). Studies show that the treatment and control of hypertension reduce the risk of cardiovascular diseases and their complications (7). In addition to beneficial effect on blood pressure, regular exercise reduces cholesterol and body fat and diseases such as arteriosclerosis (blocked arteries) (8). In addition to hyper cholesterolemia, the factors such as diabetes, smoking, inactivity, obesity, and hypertension are known as the risk factors in arteriosclerosis disease (9).

Resistin as an important inflammatory marker has a role in trauma and the development of arteriosclerosis and it has direct relationship with the risk of arteriosclerosis and High Sensitive C-reactive protein (10, 11, and 12). The reports show that Epicardial adipose tissue plays an important role in pathogenesis and the progression of Coronary artery disease with creating inflammatory adipocytokine. The Chemerin is a recently discovered Chemokine (13) found in the liver and white adipose tissue (14), and is associated with obesity, hypertension, inflammation and arteriosclerosis (15). Little research has been done regarding the effects of aerobic exercise on plasma Resistin; all show that regular aerobic activity can reduce levels of Resistin in human (16, 17). The result of studies also suggests that regular aerobic exercise has reduced Chemerin levels, body mass index and blood pressure (18, 19, 20). In addition, little research has been done about the effects of aerobic exercise on Resistin and Chemerin concentrations in postmenopausal women. Therefore, due to the little information on the effects of regular physical activity on menopausal women, this study investigated the effect of 6 weeks of regular aerobic activity on Chemerin and Resistin levels of postmenopausal women –who had hypertension disease.

The results of a study reported 15 % prevalence of hypertension in women over 18 years of Zabol in 2002 (21). Also, the mean systolic blood pressure in people over 18 years old in Mashhad has been 17.97±122.40 in 2005 (22). In recent decades, the researchers have emphasized on the effects of aerobic exercise on cardiovascular risk factors (23, 24). There is also substantial information indicating that regular aerobic activity prevents the structural and functional abnormalities of the limbs (25) and reduces the development of blood pressure (26). In research conducted in this field, the decrease of blood pressure in people with hypertension followed by regular physical activity has been reported approximately 7.5 ml of mercury (27).

Through impairment of glucose and lipid metabolism, Resistin may increase plaque vulnerability by stimulating pro-inflammatory cytokines (28). In some studies, men showed no significant change in the Resistin level up to 48 hours after aerobic exercise (29); while in others studies, regular aerobic exercise has shown good results in reducing the concentration of Resistin (30). Some research showed (31, 32) but some studies did not show (3335). Chemerin is an important factor for Adiposyte process and state regulation of genes involved in glucose and lipid balance (36). It has been reported that in Adipocytes, Chemerin enhances the insulin-stimulated glucose and causes the phosphorylation of tyrosine in Insulin receptor substrate. According to the studies, Chemerin may increase insulin sensitivity in adipose tissue and is largely associated with Body mass index, triglycerides, and blood pressure in those with normal glucose tolerance (37). Studies showed that Chemerin levels were contributed to adipose tissue and skeletal muscle and is negatively related to obesity and insulin sensitivity (38). The results also show the impact of aerobic exercise on improved cardiovascular and metabolic risk factors in obese people and reduced amount of Chemerin (39).

Other research also suggests a significant impact of sport and physical activity on blood pressure (40). Although the effect of aerobic exercise on Resistin and Chemerin concentration in postmenopausal women is unknown, the results of many studies suggest lowering effect of exercise on blood pressure; so walking and cycling have been known as other positive factors in the regulation of blood pressure (41). Augustine Sohn examined the effects of exercise (walking) in a large population of African-Americans with high blood pressure. That study was performed on 19 patients in two groups: Work and control group. They showed that more than 30 minutes of walking in a day reduces blood pressure in African-American adults who have high blood pressure (42). Exercise is the basis of health in individuals –regardless of age, sex or group. Individuals in each age or sexual group should have activity and mobility; it is more important, especially in high-risk populations (43). In this study, the followings set as the specific objectives of the study: 1) To determine the effect of a six-week regular activity and exercise on the Resistin level in postmenopausal women, 2) To determine the effect of a six-week regular activity and exercise on the Chemerin level in postmenopausal women, and 3) To determine the relation between Chemerin and Resistin level in postmenopausal women before and after six weeks of aerobic activity.

2. Material and Methods

2.1. Study design and sampling

This study was a quasi-experimental research with a pre-post test design. The population of this study included postmenopausal women diagnosed with hypertension; they were 50 to 55 years old and from Amol, a city in Mazandaran province, Iran. After required examination and verification of high pressure by the physician, 20 volunteers were selected through a purposive sampling. Participants completed a questionnaire indicating the lack of sports history during the past six months, the lack of anti-hypertension drugs use, hormone therapy, cardiovascular problems, and complete stoppage of menstrual cycle.

Filling out the personal consent and Health Questionnaire, subjects were randomly assigned to two equal groups (n=10 per group): Experimental and Control groups. The experimental group conducted a 6-week aerobic training program at 8 to 10 am. The control group did not participate in any training program. In this study, ethical considerations included the complete description of the objectives to the study participants, ensuring the confidentiality of their information.

2.2. Experiment

The aerobic exercise program of experimental group consisted of 6 weeks aerobic exercise, three times a week for 45 minutes at 50 percent maximum heart rate reserve during the first week and 60 minutes of exercise at the sixth week with 60% of maximum heart rate; thus, every two weeks, 5% was added to the intensity of aerobic activity. The aerobic activity included a 10 minutes warm-up such as stretching, exercise and running, 30 to 45 minutes main training exercises and 10 minutes cool-down exercises. The subjects were also advised to refuse any other exercise during the six-week program.

2.3. Data collection

2.3.1. Heart rate measurement

Using a stethoscope, heart rate was controlled during the aerobic exercise. The participants’ maximum heart rate was calculated using equation (Age - 220).

2.3.2. Blood Pressure Measurement

The systolic and diastolic BP of participants in the experimental group was measured before and after 6 weeks of exercise training in different circumstances in a sitting position using a mercury sphygmomanometer based on guidelines.

2.3.3. Height Measurement

The height was measured in the morning using the height gauge with an accuracy of 0.1 ± cm in the standing position without shoes, while the shoulders were in a normal condition.

2.3.4. Measurement of body weight

Weight was measured using a German digital scale with a 0.1 ± kg precision with minimal clothing without shoes. Body mass index (BMI) was calculated by dividing weight (kg) by height (in meters).

2.3.5. Blood sampling method

To examine variables, blood sampling was done on two stages: before the start of training and the sixth week. Subjects were instructed to refuse any exercise and eat light foods 24 hours before phlebotomy. Blood samples were taken of experimental and control groups after 12 hours of fasting in pre-test stage and 48 h after the last training session on the post test stage. For plasma separation, blood samples were centrifuged at the speed of 3000 rpm for 15 min and were frozen at 80 - ° C, and stored for subsequent analysis.

2.3.6. Biochemical analysis

Measurement was done using a commercial ELISA kit according to the manufacturer’s instruction.

2.4. Statistical methods

Kolmogorov-Smirnov and Levin test were used for determining the normal distribution of data and homogeneity of variances, respectively. Both dependent and independent t-tests were used to investigate the changes in the intra-group and the differences in inter-group of variables. Statistical operations were performed using SPSS 15 and the significance level of the tests was considered at P<0.05.

3. Results

The mean age of the participants was 54 years (±3.75). Table 1 shows the general characteristics of subjects in each group. The data shows that at the beginning of research, there was no significant difference between the values for age, height and body weight between the groups. Then the groups were homogeneous.

Table 1.

Mean and standard deviation of the physiological characteristics of subjects in each group (n=10, p <0.05)

Groups Age (year) Weight (kg) Height (cm)
Exercise Mean ± S.D 54 ± 3.75 29.74 ± 10.9 22.158 ± 51.7
Control Mean ± S.D 53.22 ± 4.66 44.73 ± 38.9 56.157 ± 88.1

The results in Table 2 show that the lowest concentration of Chemerin in the experimental group was after six weeks of aerobic activity was 250.66 pg/ ml and the highest concentration of Chemerin in this group was 337.48 pg/ ml. According to our findings, the lowest concentration of Chemerin in the control group after six weeks of aerobic activity was 343.70 pg ml and the highest concentration of Chemerin in this group was 348.99 pg/ml. Six weeks growing aerobic exercise has no significant effect on Chemerin concentrations in postmenopausal women. The data in Table 3 shows that the obtained t is smaller than table’s t (t=2.44); There was no significant difference between Chemerin concentrations in postmenopausal women before and after a period of six weeks (P>0.160).

Table 2.

Statistical description of chemerin and Resistin concentrations Mean (pg ml) in the exercise and control groups in terms of measures of central tendency and dispersion

Statistical indices Groups Mean Standard deviation
After Before After Before
Chemerin Exercise 250.66 337.48 31.22 35.56
Control 343.70 348.99 31.89 29.61
Resistin Exercise 2.22 3.13 0.84 0.63
Control 3.02 3.03 0.57 0.62

Table 3.

Independent t-test results to evaluate differences between Resistin concentrations before and after exercise and Chemerin concentration before and after exercise

Statistical indices Groups Mean Standard deviation Df* t value Table’s t P value
Chemerin Exercise Before exercise 337.48 35.56 6 10.41 2.44 0.000
After exercise 250.66 31.22
Control Before exercise 348.99 29.61 6 1.60 2.44 0.160
After exercise 343.70 31.89
Resistin Exercise Before exercise 3.13 0.63 6 2.42 2.44 0.051
After exercise 2.22 0.84
Control Before exercise 3.02 0.62 6 − 0.475 2.44 0.652
After exercise 3.03 0.57
*

df: Degree of freedom

Data in Table 3 shows that the obtained t is greater than table’s t (t=2.14) and there was significant difference between the Chemerin level in exercise and control groups (P < 0.05). The data in Table 3 shows that the obtained t is smaller than table’s t (t=2.44); There was no significant difference between Resistin concentrations in postmenopausal women before and after a period of six weeks (P>0.051). Table 3 also shows that the obtained t is smaller than table’s t (t=2.44); There was no significant difference between Resistin concentrations in postmenopausal women before and after a period of six weeks (P>0.625). As it is illustrated in the table 4, the obtained t is smaller than table’s t (t=2.14); There was no significant difference between Resistin concentrations in postmenopausal women before and after a period of six weeks (P>0.05). Table 5 shows that there is no significant correlation between Resistin and Chemerin changes in treatment group. It also says there is no significant correlation between Resistin and Chemerin changes in exercise group.

Table 4.

The comparison of chemerin and Resistin control and exercise group

Statistical indices Groups Mean Standard deviation Differences in the mean Df* t value Table’s t P value
Chemerin Exercise 37.2 14.14 35.27 1 4.15 2.14 0.000
Control 293.93 13.7
Resistin Exercise 3.02 0.44 0.52 1 1.15 2.14 0.130
*

df: Degree of freedom

Table 5.

Pearson correlation between Resistin and chemerin

Pearson correlation coefficient Group r P R2 P<0.05
Exercise Group Resistin - chemerin 0.033 0.944 0.0008 0.666
Control group Resistin - chemerin −0.513 0.239 0.263 0.666

4. Discussion

The results of this study show that endurance exercise decreases Chemerin and Resistin indicating the decline of inflammation and cardiovascular disease. The results are consistent with the earlier results showing regular aerobic activity can reduce levels of Resistin in human (16, 21). However, further studies on the effects of long term exercise on Chemerin and Resistin are required. Considering anti-inflammatory effects of exercise, training plays an important role in reducing inflammatory indices in human; and endurance training can be a good strategy to deal with inflammation and cardiac- vascular risk factors. This study pointed out that 6 weeks of aerobic exercise significantly reduced blood pressure in postmenopausal women with hypertension. Then, at the end of the sixth week of aerobic exercise, heart rate in postmenopausal women has increased. The results are consistent with the earlier studies (1, 9). However, period of this study and training programs was short and more evidence is required to confirm the long-term effects of exercise.

5. Conclusion

In summary, results showed that six weeks of aerobic exercise training significantly decreased Resistin, Chemerin, and blood pressure in postmenopausal women. Therefore, aerobic exercise can be used as a non-pharmacologic method to improve the health of patients with coronary artery disease and hypertension. Paying more attention to all segments of society, especially the elderly and putting a light and a regular exercise program for patients with hypertension may increase the health status of the vulnerable elderly population.

Acknowledgments

The authors would like to extend their gratitude to the Dr. Farzanegi for her invaluable support.

Footnotes

Conflict of Interest:

There is no conflict of interest to be declared.

References

  • 1.Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, Godwin J, Qizilbash N, Taylor JO, Hennekens CH. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335(8693):827–38. doi: 10.1016/0140-6736(90)90944-z. 7; [DOI] [PubMed] [Google Scholar]
  • 2.Teoman N, Ozcan A, Acar B. The effect of exercise on physical fitness and quality of life in Postmenopausal women. Maturitas. 2004;47(1):71–7. doi: 10.1016/s0378-5122(03)00241-x. 20. [DOI] [PubMed] [Google Scholar]
  • 3.Casiglia Edoardo, Palatini Paolo, Da Ros Santina, Pagliara Valeria, Puato Massimo, Dorigatti Francesca, Pauletto Paolo. Effect of Blood Pressure and Physical Activity on Carotid Artery Intima–Media Thickness in Stage 1 Hypertensives and Controls. Am J Hypertens. 2000;13(12):1256–1262. doi: 10.1016/s0895-7061(00)01211-5. [DOI] [PubMed] [Google Scholar]
  • 4.Orshal JM, Khalil RA. Gender, sex hormones, and vasculartone. Am J Physiol Regul Integr Comp Physiol. 2004;286(2):R233–49. doi: 10.1152/ajpregu.00338.2003. [DOI] [PubMed] [Google Scholar]
  • 5.Chedraui P, Blumel JE, Barone G, Belzares E, Bencosme A, Calle A, et al. Impaired quality of life among middl aged women: A multicentre latino American study. Maturitas. 2004;47:71–77. doi: 10.1016/j.maturitas.2008.09.026. [DOI] [PubMed] [Google Scholar]
  • 6.Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A. Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol. 2004;33(6):1345–52. doi: 10.1093/ije/dyh249. [DOI] [PubMed] [Google Scholar]
  • 7.Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr, Jones DW, Materson BJ, Oparil S, Wright JT, Jr, Roccella EJ, Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute. National High Blood Pressure Education Program Coordinating Committee Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206–52. doi: 10.1161/01.HYP.0000107251.49515.c2. [DOI] [PubMed] [Google Scholar]
  • 8.Kopff B, jegier A. Adipokines: adiponectin, leptin, resistin and coronary heart disease risk. Przegl lek. 2005;62(3):69–72. [PubMed] [Google Scholar]
  • 9.Hoefle G, Saely CH, Risch L, Koch L, Schmid F, Rein P, Aczél S, Berchtold S, Drexel H. Relationship between the adipose-tissue hormone resistin and coronary artery disease. Clin Chim Acta. 2007;386(1–2):1–6. doi: 10.1016/j.cca.2007.07.001. [DOI] [PubMed] [Google Scholar]
  • 10.Hansson GK. Inflammation atherosclerosis, and coronary artery disease. New engl J Med. 2005;352(16):1685–95. doi: 10.1056/NEJMra043430. [DOI] [PubMed] [Google Scholar]
  • 11.Hackam DG, Anand ss. Emerging risk factors for atherosclerotic vascular disease:a critical review of the evidence. J American medical association (JAMA) 2003;290(7):932–40. doi: 10.1001/jama.290.7.932. [DOI] [PubMed] [Google Scholar]
  • 12.Markel H, Rocchini AP, Beekman RH, Martin J, Palmisano J, Moorehead C, Rosenthal A. Exercise-Induced Hypertension After Repair of Coarctation of the Aorta: Arm Versus Leg Exercise. J Am Coll CardioI. 1986;8(1):165–71. doi: 10.1016/s0735-1097(86)80108-5. [DOI] [PubMed] [Google Scholar]
  • 13.Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brézillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003;198(7):977–85. doi: 10.1084/jem.20030382. 6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D. Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology. 2007;148(10):4687–94. doi: 10.1210/en.2007-0175. [DOI] [PubMed] [Google Scholar]
  • 15.Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, Newby LK, Waters D, Vittinghoff E, Wenger N, HERS Research Group Cardiovascular disease outcomes during 68 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERSII) J American medical association (JAMA) 2002;288(1):49–57. doi: 10.1001/jama.288.1.49. 3. [DOI] [PubMed] [Google Scholar]
  • 16.Jamurtas AZ, theocharis v, koukiulis G, stakias N, Fatouros IG, et al. the effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males. Eur J appl physiol. 2006;97(1):122–6. doi: 10.1007/s00421-006-0169-x. [DOI] [PubMed] [Google Scholar]
  • 17.Jones TE, Basilio JL, Brophy PM, Mccammon MR, Hickner RC. Long- term exercise training in over weight adolescents improves plasma peptide YY and resistin. obesity (silver spring) 2009;17(6):1189–950. doi: 10.1038/oby.2009.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bravata DM, Smith-Spangler C, Sundaram V, Gienger AL, Lin N, Lewis R, Stave CD, Olkin I, Sirard JR. Using pedometers to increase physical activity and improve health: a systematic review. J American medical association (JAMA) 2007;298(19):2296–304. doi: 10.1001/jama.298.19.2296. 21. [DOI] [PubMed] [Google Scholar]
  • 19.Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA. The hormone resistin links obesity to diabetes. Nature. 2001;409(6818):307–12. doi: 10.1038/35053000. 18. [DOI] [PubMed] [Google Scholar]
  • 20.Hughes S. Novel cardiovascular risk factors. J cardiovasc Nurs. 2003;18(2):131–8. doi: 10.1097/00005082-200304000-00009. [DOI] [PubMed] [Google Scholar]
  • 21.Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282(38):28175–88. doi: 10.1074/jbc.M700793200. [DOI] [PubMed] [Google Scholar]
  • 22.Boskabadi MH, Emad Zadeh M, Hassan Zadeh AA, Salimi N, Haji Zadeh S. Study of the level of blood pressure in subjects older than eighteen years in Mashhad. Physiology Pharmacology J. 2005;2(9):195–20. [Google Scholar]
  • 23.oberbach A, Tonjes A, Kloting N, Fasshauer M, Kratzsch J, Busse MW, et al. Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance. Eur J Endocrinol. 2006;154(4):77–85. doi: 10.1530/eje.1.02127. [DOI] [PubMed] [Google Scholar]
  • 24.Kassapis C, Thompson PD. The Effects of physical Activity on Serum C- Reactive Protein and Inflammatory Markers. J Am Coll Cardiol. 2005;45:1563–1569. doi: 10.1016/j.jacc.2004.12.077. [DOI] [PubMed] [Google Scholar]
  • 25.Zhang J, Ren CX, Qi YF, Lou LX, Chen L, Zhang LK, Wang X, Tang C. Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. Life Sci. 2006;79(12):1153–9. doi: 10.1016/j.lfs.2006.03.040. 15. [DOI] [PubMed] [Google Scholar]
  • 26.Jessup JV, Lowenthal DT, Pollock ML, Turner T. The effects of endurance exercise training on ambulatory blood pressure in normotensive older adults. Geriatr Nephrol. 1998;8(2):103–9. doi: 10.1023/a:1008287320868. [DOI] [PubMed] [Google Scholar]
  • 27.Pescatello LS, Franklin BA, Fagard R, Farquhar WB, Kelley GA, Ray CA. American College of Sports Medicine position stand. Exercise and hypertension. Med Sci Sports Exerc. 2004;36(3):533–53. doi: 10.1249/01.mss.0000115224.88514.3a. [DOI] [PubMed] [Google Scholar]
  • 28.Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, Sasaki S. Chemerin--a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun. 2007;362(4):1013–8. doi: 10.1016/j.bbrc.2007.08.104. 3. [DOI] [PubMed] [Google Scholar]
  • 29.Xu W, Yu L, Zhou W, Luo M. Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem Biophys Res Commun. 2006;351(2):376–82. doi: 10.1016/j.bbrc.2006.10.051. 15. [DOI] [PubMed] [Google Scholar]
  • 30.Jones TE, Basilio JL, Brophy PM, Mccammon MR, Hickner RC. Long- term exercise training in overweight a dolescents improves plasma peptide YY and resistin. obesity (silver spring) 2009;17(G):1189–950. doi: 10.1038/oby.2009.11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003;309(2):286–90. doi: 10.1016/j.bbrc.2003.07.003. 19. [DOI] [PubMed] [Google Scholar]
  • 32.Kim KH, Zhao L, Moon Y, Kang C, Sul HS. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci U S A. 2004;101(17):6780–5. doi: 10.1073/pnas.0305905101. 27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Konrad A, Lehrke M, Schachinger V, Seibold F, Stark R, Ochsenkühn T, Parhofer KG, Göke B, Broedl UC. Resistin is an inflammatory marker of inflammatory bowel disease in humans. Eur J Gastroenterol Hepatol. 2007;19(12):1070–4. doi: 10.1097/MEG.0b013e3282f16251. [DOI] [PubMed] [Google Scholar]
  • 34.Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 2004;1(2):e45. doi: 10.1371/journal.pmed.0010045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Moreau KL, Degarmo R, Langley J, McMahon C, Howley ET, Bassett DR, Jr, Thompson DL. Increasing daily walking lowers blood pressure in postmenopausal women. Med Sci Sports Exerc. 2001;33(11):1825–31. doi: 10.1097/00005768-200111000-00005. [DOI] [PubMed] [Google Scholar]
  • 36.Ganderton L, Jenkins S, Gain K, Fowler R, Winship P, Lunt D, Gabbay E. Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial. BMC Pulm Med. 2011;23:25. doi: 10.1186/1471-2466-11-25. 11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Crouse JH, Crouse JR, Goldbourt U, Evans G, Pinsky J, Sharrett AR, Sorlie P, Riley W, Heiss G. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke. 1996;27:69–75. doi: 10.1161/01.str.27.1.69. [DOI] [PubMed] [Google Scholar]
  • 38.Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, Arner P, Eckel J. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes. 2009;58(12):2731–40. doi: 10.2337/db09-0277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Saremi A, Shavandi N, Parastesh M, Daneshmand H. Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in over weight and obese men. Asian J Sports Med (A J M) 2010;1(3):151–8. doi: 10.5812/asjsm.34860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Gao X, Mi S, Zhang F, Gong F, Lai Y, Gao F, Zhang X, Wang L, Tao H. Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovasc Diabetol. 2011;7:87. doi: 10.1186/1475-2840-10-87. 10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Staffileno BA, Minnick A, Coke LA, Hollenberg SM. Blood pressure responses to lifestyle physical activity among young, hypertension-prone African-American women. J CardiovascNurs. 2007;22(2):107–17. doi: 10.1097/00005082-200703000-00007. [DOI] [PubMed] [Google Scholar]
  • 42.Levenstein S, Smith MW, Kaplan GA. Psychosocial predictors of hypertension in men and women. Arch Intern Med. 2001;161(10):1341–6. doi: 10.1001/archinte.161.10.1341. 28. [DOI] [PubMed] [Google Scholar]
  • 43.Pauletto P, Palatini P, DaRos S, Pagliara V, Santipolo N, Baccillieri S, Casiglia E, Mormino P, Pessina AC. Factors underlying the increase in carotid intima–media thickness in borderline hypertensives. Arterioscl Thromb Vasc Biol. 1999;19(5):1231–7. doi: 10.1161/01.atv.19.5.1231. [DOI] [PubMed] [Google Scholar]

Articles from Electronic Physician are provided here courtesy of The Electronic Physician

RESOURCES